TIMOTHY C BARABE
CIK 1237409 · Chief Financial Officer · last filed 2026-03-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.57M
Companies
7
Total Filings
267
Lifetime Open-Market Net
-$3.29M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HTFL | Director | 179,521 | $33.24 | $5.97M | $0 | 3 | 2026-03-12 |
| RNAC | Director | 56,966 | $9.51 | $541.7K | $301.0K | 6 | 2026-01-06 |
| Cartesian Therapeutics, Inc. (SELB) Delisted | Director | 250,013 | $0.88 | $220.3K | $273.7K | 20 | 2023-01-04 |
| VEEV | Director | 6,643 | $159.54 | $1.06M | -$1.35M | 39 | 2021-06-23 |
| Acer Therapeutics Inc. (OPXAW) Delisted | Director | 20,719 | — | — | $3.3K | 11 | 2016-11-22 |
| AFFYMETRIX INC (AFFX) Delisted | Chief Financial Officer | 166,378 | — | — | $337.8K | 21 | 2013-03-20 |
| HUMAN GENOME SCIENCES INC (HGSI) Delisted | Chief Financial Officer | 49,570 | — | — | -$2.85M | 16 | 2010-02-22 |
Recent Filings · Page 7 of 27
267 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-04-04 | Cartesian Therapeutics, Inc. (SELB) Delisted | Exer (M) | +2,492 | $27.4K | EDGAR |
| 2017-04-04 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-03 | VEEV | Sell (S) | −1,292 | -$65.9K | EDGAR |
| 2017-03-24 | VEEV | Exer (M) | +1,292 | $0 | EDGAR |
| 2017-02-21 | — | Grant (A) | +5,000 | $6.0K | |
| 2017-01-18 | — | Grant (A) | +784 | $1.2K | |
| 2017-01-04 | VEEV | Sell (S) | −1,292 | -$52.4K | EDGAR |
| 2016-12-27 | VEEV | Exer (M) | +1,292 | $0 | EDGAR |
| 2016-11-22 | Acer Therapeutics Inc. (OPXAW) Delisted | Sell (S) | −14,914 | -$8.2K | EDGAR |
| 2016-11-21 | — | Grant (A) | +4,285 | $6.0K |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.